Expressive proteomics profile changes of injured human brain cortex due to acute brain trauma

Brain Injury

Volumn 23, Issue 10, 2009, Pages 830-840

  Yang, Xinyu ^a   Yang, Shuyuan ^a   Wang, Jie ^b   Zhang, Xuemin ^b   Wang, Chen ^a   Hong, Guoliang ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Cortex; Human; Proteomics; Traumatic brain injury

Indexed keywords

CYTOSKELETON PROTEIN; PROTEIN;

ADULT; AGED; ARTICLE; BRAIN CORTEX; CELL CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DISEASE SEVERITY; ELECTRON TRANSPORT; FEMALE; FRONTAL CORTEX; HIGH THROUGHPUT SCREENING; HUMAN; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLISM; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; PROTEOMICS; SIGNAL TRANSDUCTION; TRAUMATIC BRAIN INJURY;

EID: 72949109330     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.1080/02699050903196670     Document Type: Article

References (57)

1. Maas A, Marmarou A, Murray G, Teasdale S, Steyerberg E. Prognosis and clinical trial design in traumatic brain injury: the IMPACT study. Journal of Neurotrauma 2007;24:232-238. (Pubitemid 46492144)
2. Crooks C, Zumsteg J, Bell K. Traumatic brain injury: a review of practice management and recent advances. Physical Medicine Rehabilitation Clinics of North America 2007;18: 681-710.
3. Marion D. Evidenced-based guidelines for traumatic brain injuries. Progress in Neurological Surgery 2006;19:171-196.
4. Gennarelli T. The pathobiology of traumatic brain injury. Neuroscientist 1997;3:73-81.
5. Gaetz M. The neurophysiology of brain injury. Clinical Neurophysiology 2004;115:4-18.
6. Werner C, Engelhard K. Pathophysiology of traumatic brain injury. British Journal of Anaesthesiology 2007;99:4-9.
7. Tomomura M, Morita N, Yoshikawa F, Konishi A, Akiyama H, Furuichi T, Kamiguchi H. Structural and functional analysis of the apoptosis-associated tyrosine kinase (AATYK) family. Neuroscience 2007;148:510-521.
8. Plesnila N, Baumgarten L, Retiounskaia M, Engel D, Ardeshiri A, Zimmermann R, Hoffmann F, Landshamer S, Wagner E, Culmsee C. Delayed neuronal death after brain trauma involves p53-dependent inhibition of NF-B transcriptional activity. Cell Death and Differentiation 2007;14: 1529-1541.
9. Alessandri B, Nishioka T, Heimann A, Bullock R, Kempski O. Caspase-dependent cell death involved in brain damage after acute subdural hematoma in rats. Brain Research 2006;1111:196-202.
10. Kiryu-Seo S, Kato R, Ogawa T, Nakagomi S, Nagata K, Kiyama H. Neuronal injury-inducible gene is synergistically regulated by ATF3, cJun and STAT3, through the interaction with Sp1 in damaged neurons. Journal of Biological Chemistry 2008;283:6988-6996.
11. Bajo M, Fruehauf J, Kim SH, Fountoukakis M, Lubec G. Proeomic evaluation of intermediary metabolism enzyme proteins in fetal Down's syndrome cerebral cortex. Proteomics 2002;2:1539-1546.
12. Bernanova-Giorgianni S, Giorgianni F, Desiderio D. Analysis of the proteome in the human pituitary. Proteomics 2002;2: 534-542.
13. Butterfield D. Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain. Brain Research 2004;1000:1-7.
14. Castegna A, Thongboonkerd V, Klein J, Lynn B, Markesbery W, Butterfield D. Proteomic identification of nitrated proteins in Alzheimer's disease brain. Journal of Neurochemistry 2003;85:1394-1401.
15. Bradford M. A rapid and sensitive method for the quantitation of protein utilizing the principle of protein dye binding. Analytical Biochemistry 1976;72:248-252.
16. Gorg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R, Weiss W. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 2000;21:1037-1053.
17. Patel K, Stein R, Benvenuti S, Zvelebil M. Combinatorial use of mRNA and two-dimensional electrophoresis expression data to choose relevant features for mass spectrometric identification. Proteomics 2002;2:1464-1473.
18. Cernak I. Recent advances in neuroprotection for treating traumatic brain injury. Expert Opinions in Investigative Drugs 2006;15:1371-1381.
19. Abdullaev Y, Posner M. How the brain recovers following damage. Nature in Neuroscience 2005;8:1424-1425.
20. Lee J, Chen K, Liu Zh. Adult motor neuron apoptosis is mediated by nitric oxide and Fas death receptor linked by DNA damage and p53 activation. Journal of Neuroscience 2005;25:6449-6459.
21. Fei Zh, Zhang X, Bai H, Jiang X, Li X, Zhang W, Hu W. Posttraumatic secondary brain insults exacerbates neuronal injury by altering metabotropic glutamate receptors. BMC Neuroscience 2007;8:96.
22. Williams A, Wei H, Dave J, Tortella F. Acute and delayed neuroinflammatory response following experimental penetrating ballistic brain injury in the rat. Journal of Neuroinflammation 2007;4:17.
23. Liu M, Akle V, Zheng W, Dave J, Tortella F, Hayes R, Wang K. Comparing calpain-and caspase-3-mediated degradation patterns in traumatic brain injury by differential proteome analysis. Biochemistry Journal 2006;394:715-725.
24. Davidsson P, Paulson L, Hesse C, Blennow K, Nilsson C. Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electrophoresis approach prior to mass spectrometry. Proteomics 2001;1: 444-452.
25. Davidsson P, Sjogren M, Andreasen N, Lindbfer M, Nilsson C, Westman-Brinkmalm A, Blennow K. Studies of the pathophysiological mechanisms in frontotemporal demenia by proteome analysis of CSF proteins. Brain Research and Molecular Brain Research 2002;109:128-133.
26. Fountoulakis M, Juranville J, Dierssen M, Lubec G. Proteomic analysis of the fetal brain. Proteomics 2002;2: 1547-1576.
27. Lubec G, Krapfenbauer K, Fountoulakis. Proteomics in brain research: potentials and limitations. Progress in Neurobiology 2003;69:193-211.
28. Kim S, Voshol H, Oostrum J, Hastings T, Cascio M, Glucksman M. Neuroproteomics: expression profiling of the brain's proteomes in health and disease. Neurochemistry Research 2004;29:1317-1331.
29. Peyrl A, Krapfenbauer K, Slavc I, Yang J, Strobel T, Lubec G. Protein profiles of medulloblastoma cell lines DAOY and D283: identification of tumor-related proteins and principles. Proteomics 2003;3:1781-1800.
30. Sultana R, Boyd-Kimball D, Poon H, Cai J, Pierce W, Klein J, Markesbery W, Zhou X, Lu K, Butterfield D. Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: a redox proteomics analysis. Neurobiology of Aging 2006;27:918-925.
31. Maurer M, Feldmann R, Futterer C, Kuschinsky W. The proteome of neural stem cells from adult rat hippocampus. Proteome Science 2003;1:4.
32. Hoffrogge R, Beyer S, Volker U, Uhrmacher A, Rolfs A. 2-DE proteomic profiling of neuronal stem cells. Neurodegenerative Diseases 2006;3:112-121.
33. Yang J, Rodrigo R, Felipo V, Lubec G. Proteome analysis of primary neurons and astrocytes from rat cerebellum. Journal of Proteome Research 2005;4:768-788.
34. Vanrobaeys F, Coster R, Dhondt G, Devreese B, Beeumen J. Profiling of myelin proteins by 2D-gel electrophoresis and multidimensional liquid chromatography coupled to MALDI TOF-TOF mass spectrometry. Journal of Proteome Research 2005;4:2283-2293.
35. Kochanek A, Kline A, Gao W, Chadha M, Lai Y, Clark R, Dixon C, Jenkins L. Gel-based hippocampal proteomic analysis 2 weeks following traumatic brain injury to immature rats using controlled cortical impact. Developmental Neuroscience 2006;28:410-419.
36. Ekegren T, Hanrieder J, Aquilonius S, Bergquist J. Focused proteomics in post-mortem human spinal cord. Journal of Proteome Research 2006;5:2364-2371.
37. Chen W, Ji J, Zhao R, Ru B. Comparative proteome analysis of human temporal cortex lobes by two-dimensional electrophoresis and identification of selected common proteins. Neurochemistry Research 2002;27:9871-9881.
38. Eun J, Chio H, Kwak Y. Proteomic analysis of human cerebral cortex in epileptic patients. Experiments in Molecular Medicine 2004;36:185-191.
39. Jenkins L, Peters G, Dixon C, Zhang X, Clark R, Skinner J, Marion D, Adelson P, Kochanek D. Conventional and functional proteomics using large format two-dimensional gel electrophoresis 24 hours after controlled cortical impact in postnatal day 17 rats. Journal of Neurotrauma 2002;19: 715-740.
40. Belli A, Sen J, Petzold A, Russo S, Kitchen N, Smith M. Metabolic failure precedes intracranial pressure rises in traumatic brain injury: a microdialysis study. Acta Neurochirgica (Wien) 2008;150:461-469.
41. Oddo M, Schmidt J, Mayer S, Chioléro R. Glucose control after severe brain injury. Current Opinions in Clinical and Nutritional Metabolic Care 2008;11:134-139.
42. Soustiel J, Sviri G. Monitoring of cerebral metabolism: nonischemic impairment of oxidative metabolism following severe traumatic brain injury. Neurology Research 2007;29: 654-660.
43. Hlatky R, Valadka A, Gopinath S, Robertson C. Brain tissue oxygen tension response to induced hyperoxia reduced in hypoperfused brain. Journal of Neurosurgery 2008;108: 53-58.
44. Loan N. Metabolic/nutritional alterations of traumatic brain injury. Nutrition 1999;15:809-812.
45. Buono P, Conciliis L, Izzo P, Salvatore F. The transcription of the human fructose-bisphosphate aldolase C gene is activated by nerve-growth-factor- induced B factor in human neuroblastoma cells. Biochemistry Journal 1997;323: 245-250.
46. Yamaji R, Fujita K, Nakanishi I, Nagao K, Naito M, Tsuruo T, Inui H, Nakano Y. Hypoxic up-regulation of triosephosphate isomerase expression in mouse brain capillary endothelial cells. Archives of Biochemistry and Biophysics 2004;423:332-342.
47. Poon H, Farr S, Thongboonkerd V, Lynn B, Banks W, Morley J, Klein J, Butterfield D. Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders. Neurochemistry International 2005;46:159-168.
48. Hanai N, Nagata K, Kawajiri A, Shiromizu T, Saitoh N, Hasegawa Y, Murakami S, Inagaki M. Biochemical and cell biological characterization of a mammalian septin, Sept 11. FEBS Letters 2004;568:83-88. (Pubitemid 38757960)
49. Kartmann B, Roth D. Novel roles for mammalian septins: from vesicle trafficking to oncogenesis. Journal of Cell Science 2001;114:839-844.
50. Field C, Kellogg D, Septins: cytoskeletal polymers or signaling GTPases? Trends in Cellular Biology 1999;9: 387-394.
51. Mills J, Digicaylioglu M, Legg A, Young C, Barr A, Fletcher L, O'Connor T, Dedhar S. Role of integrin-linked kinase in nerve growth factor-stimulated neurite outgrowth. Journal of Neuroscience 2003;23:1638-1648.
52. Kaneko Y, Kitazato K, Basaki Y. Integrin-linked kinase regulates vascular morphogenesis induced by vascular endothelial growth factor. Journal of Cellular Science 2004;117:407-415.
53. Yoganathan N, Yee A, Zhang Z. Integrin-linked kinase, a promising cancer therapeutic target: biochemical and biological properties. Pharmacological Therapy 2002;93:233-242.
54. Renault F, Formstecher E, Callebaut I, Junier MP, Chneiweiss H. The multifunctional protein PEA-15 is involved in the control of apoptosis and cell cycle in astrocytes. Biochemistry and Pharmacology 2003;66: 1581-1588.
55. Formsstecher E, Ramos J, Fauquet M, Calderwood D, Hsieh J, Canton B, Nguyen X, Barnier J, Camonis J, Ginsberg M. PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Development of the Cell 2001;1:239-250.
56. Chin L, Fu Q, Kachinsky A, Jabren G, Niu Y, Li L. Neuronspecific and developmental regulation of the synapsin II gene expression in transgenic mice. Brain Research and Molecular Brain Research 1999;67:239-246.
57. Leypoldt F, Flajolet M, Mether A. Neuronal differentiation of cultured human NTERA-2cl.D1 cells leads to increased expression of synapsins. Neuroscience Letters 2002;324: 37-40.